These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15340047)

  • 1. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and regulation of RhoE.
    Riento K; Villalonga P; Garg R; Ridley A
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):649-51. PubMed ID: 16042565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
    Fan J; Bertino JR
    Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell line.
    Poch E; Miñambres R; Mocholí E; Ivorra C; Pérez-Aragó A; Guerri C; Pérez-Roger I; Guasch RM
    Exp Cell Res; 2007 Feb; 313(4):719-31. PubMed ID: 17182035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
    Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ROCK by RhoE.
    Riento K; Ridley AJ
    Methods Enzymol; 2006; 406():533-41. PubMed ID: 16472685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells.
    Liberto M; Cobrinik D; Minden A
    Oncogene; 2002 Feb; 21(10):1590-9. PubMed ID: 11896588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.
    Coutts M; Zou X; Calame K
    Oncogene; 2000 Feb; 19(6):801-9. PubMed ID: 10698498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton.
    Coleman ML; Densham RM; Croft DR; Olson MF
    Oncogene; 2006 May; 25(19):2708-16. PubMed ID: 16407839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Sinibaldi D; Wharton W; Turkson J; Bowman T; Pledger WJ; Jove R
    Oncogene; 2000 Nov; 19(48):5419-27. PubMed ID: 11114718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27kip1-independent cell cycle regulation by MYC.
    Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
    Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
    Villalonga P; Fernández de Mattos S; Ridley AJ
    J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
    Bektic J; Pfeil K; Berger AP; Ramoner R; Pelzer A; Schäfer G; Kofler K; Bartsch G; Klocker H
    Prostate; 2005 Sep; 64(4):332-40. PubMed ID: 15754346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
    Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M
    Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.